“Long-Term Safety and Efficacy of Belzutifan in Von Hippel–Lindau Syndrome: A VHL Coordinating Care Center Experience”. Journal of Kidney Cancer 12, no. 3 (September 5, 2025): 25–31. Accessed April 30, 2026. https://www.jkcvhl.com/index.php/jkcvhl/article/view/425.